|
|
Volumn 26, Issue 2, 1997, Pages 505-506
|
|
Ribavirin and interferon for recurrent posttransplantation HCV infection: To treat or not to treat?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
RECOMBINANT ALPHA2B INTERFERON;
RIBAVIRIN;
VIRUS RNA;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EDITORIAL;
GRAFT SURVIVAL;
HEMOLYTIC ANEMIA;
HEPATITIS C VIRUS;
HUMAN;
HUMAN TISSUE;
LIVER FUNCTION TEST;
LIVER HISTOLOGY;
LIVER TRANSPLANTATION;
PRIORITY JOURNAL;
RECURRENT VIRUS INFECTION;
RISK BENEFIT ANALYSIS;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
HEPATITIS C;
HUMANS;
INTERFERON-ALPHA;
LIVER TRANSPLANTATION;
RECURRENCE;
RIBAVIRIN;
|
|
EID: 0030839655
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.510260238 Document Type: Editorial |
|
Times cited : (9)
|
|
References (11)
|
